CRTE7A2-01 TCR-T Cells for HPV-16 Positive Advanced Cancers
Clinical trial NCT06358053 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06358053
- Sponsor
- Corregene Biotechnology Co., Ltd
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-15
- Primary completion
- 2027-12-31
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.